SCHEMBL22010059

SCHEMBL22010059

N=C(CCc1ccc(-c2ccc(Cl)cc2)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.49
MAP4K4 O95819 1/20 0.47
MAOB P27338 1/20 0.46
PDPK1 O15530 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CNR1 P21554 1/20 0.44
PLAAT3 P53816 4/20 0.44
PLAAT5 Q96KN8 4/20 0.44
PLAAT2 Q9NWW9 4/20 0.44
PLAAT4 Q9UL19 4/20 0.44
MMP12 P39900 1/20 0.44
MCHR1 Q99705 2/20 0.43
FFAR4 Q5NUL3 1/20 0.43
CHRM1 P11229 1/20 0.43
HTR2A P28223 1/20 0.43
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010460 0.82 CTBP2 (0.51) MEN1KMT2A
SCHEMBL27825386 0.79 PLAAT3 (0.53) FFAR1PDPK1MEN1KMT2ACNR1
SCHEMBL4591629 0.77 MAOB (0.55) FFAR1MAP4K4MAOBPDPK1MEN1
SCHEMBL28222567 0.77 LOXL2 (0.44) FFAR1HDAC6HDAC3
SCHEMBL7271458 0.76 PLAAT3 (0.59) FFAR1PDPK1MEN1KMT2APLAAT3
SCHEMBL349314 0.75 FFAR1 (0.71) FFAR1MAP4K4PDPK1MEN1KMT2A
SCHEMBL3869891 0.75 HDAC3 (0.60) FFAR1MAP4K4HDAC1HDAC6HDAC3
Guanidine SCHEMBL5348315 0.75 FFAR1 (0.61) FFAR1MAP4K4PDPK1MEN1KMT2A
SCHEMBL2774874 0.74 CNR1 (0.64) CNR1PLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL5844891 0.74 PLAAT3 (0.51) FFAR1PDPK1MEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157144-A1 ANTIMICROBIAL PEPTIDOMIMETICS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157144-A1 ANTIMICROBIAL PEPTIDOMIMETICS NGLY1, GLMN, GMPS FFAR1 1393/4885MAP4K4 2729/4885MAOB 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.